Latest Breaking News On - Ungil chung - Page 1 : comparemela.com

University of Tokyo, Astellas Enter Second Phase of Strategic Partnership for Co-creation of Innovative New Medicines and Medical Solutions

University of Tokyo, Astellas Enter Second Phase of Strategic Partnership for Co-creation of Innovative New Medicines and Medical Solutions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ungil chungKenji yasukawaYoshitsugu shitakaTeruo fujiiHidenori ichijoUniversity of tokyo centerSchool of medicineSteering committeeAstellas alliance acceleration programSchool of pharmaceutical sciencesSchool of engineeringAstellas pharma incInstitute for life science researchUniversity of tokyoAstellas pharmaLife science research

University of Tokyo, Astellas Enter Second Phase of Strategic Partnership for Co-creation of Innovative New Medicines and Medical Solutions

TOKYO, April 25, 2022 /PRNewswire/ The University of Tokyo (President: Teruo Fujii, Ph.D.) and Astellas Pharma Inc. (TSE: 4503, President and C.

Ungil chungKenji yasukawaYoshitsugu shitakaTeruo fujiiHidenori ichijoUniversity of tokyo centerSchool of medicineSteering committeeAstellas alliance acceleration programSchool of pharmaceutical sciencesSchool of engineeringAstellas pharma incInstitute for life science researchUniversity of tokyoAstellas pharmaLife science research

University of Tokyo, Astellas Enter Second Phase of Strategic Partnership for Co-creation of Innovative New Medicines and Medical Solutions

/PRNewswire/ The University of Tokyo (President: Teruo Fujii, Ph.D.) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.;.

Ungil chungKenji yasukawaYoshitsugu shitakaTeruo fujiiHidenori ichijoUniversity of tokyo centerSchool of medicineSteering committeeAstellas alliance acceleration programSchool of pharmaceutical sciencesSchool of engineeringAstellas pharma incInstitute for life science researchUniversity of tokyoAstellas pharmaLife science research